National Stock Number
6810-01-504-0942
National Stock Number (NSN) 6810-01-504-0942, or NIIN 015040942, (lead) was assigned January 16, 2003 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.
There is only one manufacturer part number associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by one supplier. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.
This part number has been procured by the US Government within the last year, but shows no recent (last 90 days) procurement activity. There have been 11 contracts issued for this part number, with 3 awards given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPE4A625FZ27F, SPE4A625FZ27G, SPE4A625FZ27J, SPE4A625FZ27A, SPE4A625FZ27E. The total value of the awarded contracts has been US$ 366.73.
Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Feb 17, 2010, this NSN's acquisition method was noted as: Not established. Not established.
This NSN is assigned to Item Name Code (INC) 12632. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table I of Federal Standard 313 and an MSDS should be available to the user. NSN 6810015040942 does not contain precious metals.
This NSN is associated to Schedule B 3822000002: diagnostic or lab reagents on a backing, prepared diag/lab reagents whether or not on a backing, not of heading 3002 or 3006; certified ref materials. The Schedule B End Use is listed as chemicals-other. NAICS classification category 325412: pharmaceutical preparation manufacturing.
This information was last updated on Jul 01, 2025.